Literature DB >> 22644217

[Guideline for the prevention and early detection of breast and ovarian cancer in high risk patients, particularly in women from HBOC (hereditary breast and ovarian cancer) families].

Christian F Singer1, Muy-Kheng Tea, Gunda Pristauz, Michael Hubalek, Christine Rappaport, Christopher Riedl, Thomas Helbich.   

Abstract

The Austrian guideline for prevention and early detection of breast and ovarian cancer in high risk patients--particularly in women from hereditary breast and ovarian cancer families--were established with particular consideration of the most recent position paper of the European Society of Breast Cancer Specialists (EUSOMA) by the authors mentioned above. The guideline is aimed at facilitating and standardizing the care and early detection strategies in women with an elevated life time risk for breast and ovarian cancer.

Entities:  

Mesh:

Year:  2012        PMID: 22644217     DOI: 10.1007/s00508-012-0173-6

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  16 in total

1.  Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancer.

Authors:  Mieke Kriege; Cecile T M Brekelmans; Inge Marie Obdeijn; Carla Boetes; Harmine M Zonderland; Sara H Muller; Theo Kok; Radu A Manoliu; A Peter E Besnard; Madeleine M A Tilanus-Linthorst; Caroline Seynaeve; Carina C M Bartels; Reini Kaas; Siebren Meijer; Jan C Oosterwijk; Nicoline Hoogerbrugge; Rob A E M Tollenaar; Emiel J T Rutgers; Harry J de Koning; Jan G M Klijn
Journal:  Breast Cancer Res Treat       Date:  2006-06-22       Impact factor: 4.872

2.  Management of an inherited predisposition to breast cancer.

Authors:  Francesco Sardanelli; Franca Podo
Journal:  N Engl J Med       Date:  2007-10-18       Impact factor: 91.245

Review 3.  Oophorectomy for breast cancer prevention in women with BRCA1 or BRCA2 mutations.

Authors:  Kelly A Metcalfe
Journal:  Womens Health (Lond)       Date:  2009-01

4.  Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.

Authors:  Susan M Domchek; Tara M Friebel; Christian F Singer; D Gareth Evans; Henry T Lynch; Claudine Isaacs; Judy E Garber; Susan L Neuhausen; Ellen Matloff; Rosalind Eeles; Gabriella Pichert; Laura Van t'veer; Nadine Tung; Jeffrey N Weitzel; Fergus J Couch; Wendy S Rubinstein; Patricia A Ganz; Mary B Daly; Olufunmilayo I Olopade; Gail Tomlinson; Joellen Schildkraut; Joanne L Blum; Timothy R Rebbeck
Journal:  JAMA       Date:  2010-09-01       Impact factor: 56.272

5.  Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group.

Authors:  Francesco Sardanelli; Carla Boetes; Bettina Borisch; Thomas Decker; Massimo Federico; Fiona J Gilbert; Thomas Helbich; Sylvia H Heywang-Köbrunner; Werner A Kaiser; Michael J Kerin; Robert E Mansel; Lorenza Marotti; Laura Martincich; Louis Mauriac; Hanne Meijers-Heijboer; Roberto Orecchia; Pietro Panizza; Antonio Ponti; Arnie D Purushotham; Peter Regitnig; Marco Rosselli Del Turco; Fabienne Thibault; Robin Wilson
Journal:  Eur J Cancer       Date:  2010-03-19       Impact factor: 9.162

6.  Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.

Authors:  Kelly Metcalfe; Henry T Lynch; Parviz Ghadirian; Nadine Tung; Ivo Olivotto; Ellen Warner; Olufunmilayo I Olopade; Andrea Eisen; Barbara Weber; Jane McLennan; Ping Sun; William D Foulkes; Steven A Narod
Journal:  J Clin Oncol       Date:  2004-06-15       Impact factor: 44.544

7.  Magnetic resonance imaging of the breast improves detection of invasive cancer, preinvasive cancer, and premalignant lesions during surveillance of women at high risk for breast cancer.

Authors:  Christopher C Riedl; Lothar Ponhold; Daniel Flöry; Michael Weber; Regina Kroiss; Teresa Wagner; Michael Fuchsjäger; Thomas H Helbich
Journal:  Clin Cancer Res       Date:  2007-10-15       Impact factor: 12.531

8.  Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.

Authors:  Ellen Warner; Donald B Plewes; Kimberley A Hill; Petrina A Causer; Judit T Zubovits; Roberta A Jong; Margaret R Cutrara; Gerrit DeBoer; Martin J Yaffe; Sandra J Messner; Wendy S Meschino; Cameron A Piron; Steven A Narod
Journal:  JAMA       Date:  2004-09-15       Impact factor: 56.272

9.  Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.

Authors:  Noah D Kauff; Susan M Domchek; Tara M Friebel; Mark E Robson; Johanna Lee; Judy E Garber; Claudine Isaacs; D Gareth Evans; Henry Lynch; Rosalind A Eeles; Susan L Neuhausen; Mary B Daly; Ellen Matloff; Joanne L Blum; Paul Sabbatini; Richard R Barakat; Clifford Hudis; Larry Norton; Kenneth Offit; Timothy R Rebbeck
Journal:  J Clin Oncol       Date:  2008-02-11       Impact factor: 44.544

10.  Clinical management recommendations for surveillance and risk-reduction strategies for hereditary breast and ovarian cancer among individuals carrying a deleterious BRCA1 or BRCA2 mutation.

Authors:  Doug Horsman; Brenda J Wilson; Denise Avard; Wendy S Meschino; Charmaine Kim Sing; Marie Plante; Andrea Eisen; Heather E Howley; Jacques Simard
Journal:  J Obstet Gynaecol Can       Date:  2007-01
View more
  6 in total

1.  Evaluation of BRCA1/2 mutational status among German and Austrian women with triple-negative breast cancer.

Authors:  Axel Muendlein; Bettina H Rohde; Klaus Gasser; Anton Haid; Stephanie Rauch; Elena Kinz; Heinz Drexel; Wera Hofmann; Verena Schindler; Rita Kapoor; Thomas Decker; Alois H Lang
Journal:  J Cancer Res Clin Oncol       Date:  2015-05-15       Impact factor: 4.553

2.  Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density.

Authors:  Christopher C Riedl; Nikolaus Luft; Clemens Bernhart; Michael Weber; Maria Bernathova; Muy-Kheng M Tea; Margaretha Rudas; Christian F Singer; Thomas H Helbich
Journal:  J Clin Oncol       Date:  2015-02-23       Impact factor: 44.544

3.  AGO Austria recommendations for genetic testing of patients with ovarian cancer.

Authors:  Christian Marth; Michael Hubalek; Edgar Petru; Stephan Polterauer; Alexander Reinthaller; Christian Schauer; Tonja Scholl-Firon; Christian F Singer; Johannes Zschocke; Alain G Zeimet
Journal:  Wien Klin Wochenschr       Date:  2015-08       Impact factor: 1.704

4.  Changes of Socio-demographic data of clients seeking genetic counseling for hereditary breast and ovarian cancer due to the "Angelina Jolie Effect".

Authors:  Christine Staudigl; Georg Pfeiler; Katharina Hrauda; Romana Renz; Andreas Berger; Renate Lichtenschopf; Christian F Singer; Muy-Kheng M Tea
Journal:  BMC Cancer       Date:  2016-07-08       Impact factor: 4.430

5.  Understanding the role of CD44V6 in ovarian cancer.

Authors:  Hui-Feng Zhang; Peng Hu; Sheng-Quan Fang
Journal:  Oncol Lett       Date:  2017-06-13       Impact factor: 2.967

6.  Improving comprehension of genetic counseling for hereditary breast and ovarian cancer clients with a visual tool.

Authors:  Muy-Kheng M Tea; Yen Y Tan; Christine Staudigl; Birgit Eibl; Romana Renz; Ella Asseryanis; Andreas Berger; Georg Pfeiler; Christian F Singer
Journal:  PLoS One       Date:  2018-07-12       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.